Executive Solution Overview
– 2 years ago **files (2)** – ## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx – ## DiabetesType11.docx **## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx** **This is the second part and professor feedback of first part** **Feedback** make sure to use an appropriate tool on week …
Instant Solution Download
$6.99Immediate access to the full model answer, formatted citations, and rubric breakdown.
Need a Fresh Custom Paper?
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Assignment Prompt & Instructions
– 2 years ago
**files (2)**
– ## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx
– ## DiabetesType11.docx
**## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx**
**This is the second part and professor feedback of first part**
**Feedback** make sure to use an appropriate tool on week 12 when evaluating the outcomes,
**Chosen Evidence-Based Technology Use in Disease or Risk Factor**
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
**Conclusion**
-Recap points discussed in the paper
-Importance of advancements in technology
**Signature Assignment. Submit the complete paper including the conclusion**
Completion requirements
**Opened:** Monday, March 24, 2025, 11:00 AM
**Due:** Sunday, March 30, 2025, 11:00 PM
Full description of the assignment is included at the end of the syllabus.
In this section the students needs to submit a complete assignment. Which includes: Introduction, Body and Conclusion.
Introduction:
**Introduction:**
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
**Body of the Paper**
**Global Burden of Disease Condition/Risk Factor**
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
**Technology and Healthcare**
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
**## DiabetesType11.docx**
Diabetes Type 1: Improving Outcomes through Technology
Student
Instructor
University affiliation
Class Name
Date
**Diabetes Type 1: Improving Outcomes through Technology**
**Introduction**
Children and young adults develop Type 1 diabetes which needs continuous life-long healthcare. The immune system accidentally damages pancreatic beta cells that make insulin which causes insulin to drop below normal levels. Type 2 diabetes normally develops because of unhealthy behaviors yet Type 1 diabetes depends mainly on genetics and surrounding conditions. The world experiences rising numbers of people affected by T1D which now totals 9 million cases. People with T1D need to control their blood sugar levels to avoid developing life-threatening DKA and avoid nerve and heart diseases plus eye problems (Addala et al., 2021). Uncontrolled diabetes causes patients to need frequent hospital visits and eventually becomes disabling. As technology keeps advancing people with diabetes can now receive better treatment options to improve their health and daily life. Advanced digital health solutions such as CGM and insulin pumps alongside digital health technology now help patients manage their diabetes care better.
**Global Burden of Disease Condition**
The global health problem of T1D mainly affects children and teenagers with no age or geographic boundaries. More T1D cases require us to find better ways to provide healthcare services to patients. People with Type 1 Diabetes need insulin treatment to survive since their condition differs from Type 2 which responds to lifestyle changes. The body's immune system starts hurting the pancreas for no clear reasons with T1D and this disease develops unpredictably (Agarwal et al., 2021).
**Signs and Symptoms**
T1D develops when patients show hyperglycemic effects such as intense thirst (polydipsia), heavy urination (polyuria), unexpected weight loss, persistent tiredness, and vision problems. Young people typically display changes in their moods and do not pay attention well during class time. When T1D remains untreated it turns into DKA which becomes an emergency condition that causes strong nausea and vomiting plus stomach pain alongside sweet breath smells and confusion before putting a patient into a coma. Patients need urgent medical care at the hospital to treat DKA.
**Diagnosis and Treatment**
Doctors identify Type 1 diabetes using multiple blood measurements including how patients handle fasting glucose levels and HbA1c alongside tests for autoantibodies linked to diabetes. When people with diabetes experience symptoms and their blood sugar levels exceed 200 mg/dL on a random test it signifies they have the condition. Patients who receive their T1D diagnosis need permanent insulin treatment either through multiple daily injections or continuous subcutaneous insulin infusions pumping (CGMS) systems. Beside insulin treatment T1D management needs patients to track their diet habits and activities plus perform regular glucose tests to prevent dangerous blood sugar levels. Our aim is to manage blood glucose values at certain levels to decrease the chances of developing diabetes complications.
**Technology and Healthcare**
Technology has transformed how healthcare manages chronic diseases across all settings of care. Modern medical devices such as CGM systems insulin pumps and artificial pancreas systems revolutionize how healthcare professionals handle diabetes. Our new technologies show blood sugar levels in real time while controlling insulin actions and sharing performance results. New digital healthcare tools help patients talk to doctors online in real time which makes them visit hospitals less often.
**Improving Health Outcomes through Technology**
New technology enhances T1D management by showing blood sugar data in real time plus alerts patients before extreme glucose changes and decreases their risk of severe hypoglycemia and hyperglycemia. The healthcare provider monitors patient glucose data from a distance and customizes health care approach based on results. The diabetes management mobile apps allow patients to measure their food carbs while recording their insulin and exercise habits. Researchers test how machine learning and artificial intelligence technologies can identify future blood sugar patterns and suggest custom insulin changes.
**Chosen Evidence-Based Technology Use in Disease Management**
Continuous Glucose Monitoring (CGM) technology has emerged as an important tool to manage Type 1 diabetes better. CGMs show blood sugar numbers right now and help detect dangerous blood sugar drops and rises which enable better T1D handling. With CGMs patients avoid frequent fingerprick blood tests because these devices directly monitor glucose levels from beneath the skin.
**Benefits of CGM Use**
Research proves that continuous glucose monitoring (CGM) systems lower HbA1c readings while making glucose levels more steady and lowering how often severe hypoglycemia happens (Majidi et al., 2021). CGMs help patients better control their condition while lowering diabetes stress and enhancing their lifestyle. CGM systems help patients spot dangerous blood sugar levels so they can start treatment at once to avoid health problems. Shoppers today can connect their CGMs to smartphone applications which show their blood sugar levels in real time and let them pass results to doctors for better care. CGMs help parents monitor their children's blood sugar levels from any location which brings peace to both parties.
**Challenges of CGM Use**
While CGM offers many benefits new users encounter substantial issues including high expense and limited availability plus short sensor life. Insurance companies do not support CGM payment which becomes expensive for many patients to afford. Some patients find sensor placement uncomfortable and deal with too many data points that cause them to get tired of using the system. The device shows imprecise measurements when the user has incorrect hydration levels or improper device setup steps. Technology enhancements create better CGMs that are easier to use and less expensive (Eberle & Stichling, 2021). Modern CGM systems let users wear sensors for longer periods because both sensor and pump connect automatically during factory calibration.
**Conclusion**
Technology integration in diabetes care brings better healthcare results especially to Type 1 Diabetes patients. Continuous Glucose Monitoring technology leads to improved blood sugar control and reduced health problems while making life for patients much better. The future of diabetes treatment depends on new developments in digital health through artificial pancreas technology which regulates insulin delivery based on live glucose measurements. Healthcare technology advances require us to make patient resources available at reasonable costs while teaching people how to use these tools effectively. Medical groups and government agencies must work together with research experts to provide people with new diabetes control methods. Using technology systems can help healthcare teams deliver better care to people with T1D which leads to better health results and enhances their daily life.
References
Addala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., … & Holl, R. W. (2021). A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison.
_Diabetes Care_,
_44_(1), 133-140.
[https://doi.org/10.2337/dc20-0257](https://doi.org/10.2337/dc20-0257)
Agarwal, S., Schechter, C., Gonzalez, J., & Long, J. A. (2021). Racial–ethnic disparities in diabetes technology use among young adults with type 1 diabetes.
_Diabetes Technology & Therapeutics_,
_23_(4), 306-313.
[https://doi.org/10.1089/dia.2020.0338](https://doi.org/10.1089/dia.2020.0338)
Eberle, C., & Stichling, S. (2021). Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: systematic meta-review.
_Journal of medical Internet research_,
_23_(2), e23244.
[https://doi.org/10.2196/23244](https://doi.org/10.2196/23244)
Majidi, S., Ebekozien, O., Noor, N., Lyons, S. K., McDonough, R., Gandhi, K., … & T1D Exchange Quality Improvement Collaborative Study Group. (2021). Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative.
_Clinical Diabetes_,
_39_(3), 278-283.
[https://doi.org/10.2337/cd21-0028](https://doi.org/10.2337/cd21-0028)
**## DiabetesType11.docx**
Diabetes Type 1: Improving Outcomes through Technology
Student
Instructor
University affiliation
Class Name
Date
**Diabetes Type 1: Improving Outcomes through Technology**
**Introduction**
Children and young adults develop Type 1 diabetes which needs continuous life-long healthcare. The immune system accidentally damages pancreatic beta cells that make insulin which causes insulin to drop below normal levels. Type 2 diabetes normally develops because of unhealthy behaviors yet Type 1 diabetes depends mainly on genetics and surrounding conditions. The world experiences rising numbers of people affected by T1D which now totals 9 million cases. People with T1D need to control their blood sugar levels to avoid developing life-threatening DKA and avoid nerve and heart diseases plus eye problems (Addala et al., 2021). Uncontrolled diabetes causes patients to need frequent hospital visits and eventually becomes disabling. As technology keeps advancing people with diabetes can now receive better treatment options to improve their health and daily life. Advanced digital health solutions such as CGM and insulin pumps alongside digital health technology now help patients manage their diabetes care better.
**Global Burden of Disease Condition**
The global health problem of T1D mainly affects children and teenagers with no age or geographic boundaries. More T1D cases require us to find better ways to provide healthcare services to patients. People with Type 1 Diabetes need insulin treatment to survive since their condition differs from Type 2 which responds to lifestyle changes. The body's immune system starts hurting the pancreas for no clear reasons with T1D and this disease develops unpredictably (Agarwal et al., 2021).
**Signs and Symptoms**
T1D develops when patients show hyperglycemic effects such as intense thirst (polydipsia), heavy urination (polyuria), unexpected weight loss, persistent tiredness, and vision problems. Young people typically display changes in their moods and do not pay attention well during class time. When T1D remains untreated it turns into DKA which becomes an emergency condition that causes strong nausea and vomiting plus stomach pain alongside sweet breath smells and confusion before putting a patient into a coma. Patients need urgent medical care at the hospital to treat DKA.
**Diagnosis and Treatment**
Doctors identify Type 1 diabetes using multiple blood measurements including how patients handle fasting glucose levels and HbA1c alongside tests for autoantibodies linked to diabetes. When people with diabetes experience symptoms and their blood sugar levels exceed 200 mg/dL on a random test it signifies they have the condition. Patients who receive their T1D diagnosis need permanent insulin treatment either through multiple daily injections or continuous subcutaneous insulin infusions pumping (CGMS) systems. Beside insulin treatment T1D management needs patients to track their diet habits and activities plus perform regular glucose tests to prevent dangerous blood sugar levels. Our aim is to manage blood glucose values at certain levels to decrease the chances of developing diabetes complications.
**Technology and Healthcare**
Technology has transformed how healthcare manages chronic diseases across all settings of care. Modern medical devices such as CGM systems insulin pumps and artificial pancreas systems revolutionize how healthcare professionals handle diabetes. Our new technologies show blood sugar levels in real time while controlling insulin actions and sharing performance results. New digital healthcare tools help patients talk to doctors online in real time which makes them visit hospitals less often.
**Improving Health Outcomes through Technology**
New technology enhances T1D management by showing blood sugar data in real time plus alerts patients before extreme glucose changes and decreases their risk of severe hypoglycemia and hyperglycemia. The healthcare provider monitors patient glucose data from a distance and customizes health care approach based on results. The diabetes management mobile apps allow patients to measure their food carbs while recording their insulin and exercise habits. Researchers test how machine learning and artificial intelligence technologies can identify future blood sugar patterns and suggest custom insulin changes.
**Chosen Evidence-Based Technology Use in Disease Management**
Continuous Glucose Monitoring (CGM) technology has emerged as an important tool to manage Type 1 diabetes better. CGMs show blood sugar numbers right now and help detect dangerous blood sugar drops and rises which enable better T1D handling. With CGMs patients avoid frequent fingerprick blood tests because these devices directly monitor glucose levels from beneath the skin.
**Benefits of CGM Use**
Research proves that continuous glucose monitoring (CGM) systems lower HbA1c readings while making glucose levels more steady and lowering how often severe hypoglycemia happens (Majidi et al., 2021). CGMs help patients better control their condition while lowering diabetes stress and enhancing their lifestyle. CGM systems help patients spot dangerous blood sugar levels so they can start treatment at once to avoid health problems. Shoppers today can connect their CGMs to smartphone applications which show their blood sugar levels in real time and let them pass results to doctors for better care. CGMs help parents monitor their children's blood sugar levels from any location which brings peace to both parties.
**Challenges of CGM Use**
While CGM offers many benefits new users encounter substantial issues including high expense and limited availability plus short sensor life. Insurance companies do not support CGM payment which becomes expensive for many patients to afford. Some patients find sensor placement uncomfortable and deal with too many data points that cause them to get tired of using the system. The device shows imprecise measurements when the user has incorrect hydration levels or improper device setup steps. Technology enhancements create better CGMs that are easier to use and less expensive (Eberle & Stichling, 2021). Modern CGM systems let users wear sensors for longer periods because both sensor and pump connect automatically during factory calibration.
**Conclusion**
Technology integration in diabetes care brings better healthcare results especially to Type 1 Diabetes patients. Continuous Glucose Monitoring technology leads to improved blood sugar control and reduced health problems while making life for patients much better. The future of diabetes treatment depends on new developments in digital health through artificial pancreas technology which regulates insulin delivery based on live glucose measurements. Healthcare technology advances require us to make patient resources available at reasonable costs while teaching people how to use these tools effectively. Medical groups and government agencies must work together with research experts to provide people with new diabetes control methods. Using technology systems can help healthcare teams deliver better care to people with T1D which leads to better health results and enhances their daily life.
References
Addala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., … & Holl, R. W. (2021). A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison.
_Diabetes Care_,
_44_(1), 133-140.
[https://doi.org/10.2337/dc20-0257](https://doi.org/10.2337/dc20-0257)
Agarwal, S., Schechter, C., Gonzalez, J., & Long, J. A. (2021). Racial–ethnic disparities in diabetes technology use among young adults with type 1 diabetes.
_Diabetes Technology & Therapeutics_,
_23_(4), 306-313.
[https://doi.org/10.1089/dia.2020.0338](https://doi.org/10.1089/dia.2020.0338)
Eberle, C., & Stichling, S. (2021). Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: systematic meta-review.
_Journal of medical Internet research_,
_23_(2), e23244.
[https://doi.org/10.2196/23244](https://doi.org/10.2196/23244)
Majidi, S., Ebekozien, O., Noor, N., Lyons, S. K., McDonough, R., Gandhi, K., … & T1D Exchange Quality Improvement Collaborative Study Group. (2021). Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative.
_Clinical Diabetes_,
_39_(3), 278-283.
[https://doi.org/10.2337/cd21-0028](https://doi.org/10.2337/cd21-0028)
**## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx**
**This is the second part and professor feedback of first part**
**Feedback** make sure to use an appropriate tool on week 12 when evaluating the outcomes,
**Chosen Evidence-Based Technology Use in Disease or Risk Factor**
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
**Conclusion**
-Recap points discussed in the paper
-Importance of advancements in technology
**Signature Assignment. Submit the complete paper including the conclusion**
Completion requirements
**Opened:** Monday, March 24, 2025, 11:00 AM
**Due:** Sunday, March 30, 2025, 11:00 PM
Full description of the assignment is included at the end of the syllabus.
In this section the students needs to submit a complete assignment. Which includes: Introduction, Body and Conclusion.
Introduction:
**Introduction:**
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
**Body of the Paper**
**Global Burden of Disease Condition/Risk Factor**
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
**Technology and Healthcare**
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
**## DiabetesType11.docx**
Diabetes Type 1: Improving Outcomes through Technology
Student
Instructor
University affiliation
Class Name
Date
**Diabetes Type 1: Improving Outcomes through Technology**
**Introduction**
Children and young adults develop Type 1 diabetes which needs continuous life-long healthcare. The immune system accidentally damages pancreatic beta cells that make insulin which causes insulin to drop below normal levels. Type 2 diabetes normally develops because of unhealthy behaviors yet Type 1 diabetes depends mainly on genetics and surrounding conditions. The world experiences rising numbers of people affected by T1D which now totals 9 million cases. People with T1D need to control their blood sugar levels to avoid developing life-threatening DKA and avoid nerve and heart diseases plus eye problems (Addala et al., 2021). Uncontrolled diabetes causes patients to need frequent hospital visits and eventually becomes disabling. As technology keeps advancing people with diabetes can now receive better treatment options to improve their health and daily life. Advanced digital health solutions such as CGM and insulin pumps alongside digital health technology now help patients manage their diabetes care better.
**Global Burden of Disease Condition**
The global health problem of T1D mainly affects children and teenagers with no age or geographic boundaries. More T1D cases require us to find better ways to provide healthcare services to patients. People with Type 1 Diabetes need insulin treatment to survive since their condition differs from Type 2 which responds to lifestyle changes. The body's immune system starts hurting the pancreas for no clear reasons with T1D and this disease develops unpredictably (Agarwal et al., 2021).
**Signs and Symptoms**
T1D develops when patients show hyperglycemic effects such as intense thirst (polydipsia), heavy urination (polyuria), unexpected weight loss, persistent tiredness, and vision problems. Young people typically display changes in their moods and do not pay attention well during class time. When T1D remains untreated it turns into DKA which becomes an emergency condition that causes strong nausea and vomiting plus stomach pain alongside sweet breath smells and confusion before putting a patient into a coma. Patients need urgent medical care at the hospital to treat DKA.
**Diagnosis and Treatment**
Doctors identify Type 1 diabetes using multiple blood measurements including how patients handle fasting glucose levels and HbA1c alongside tests for autoantibodies linked to diabetes. When people with diabetes experience symptoms and their blood sugar levels exceed 200 mg/dL on a random test it signifies they have the condition. Patients who receive their T1D diagnosis need permanent insulin treatment either through multiple daily injections or continuous subcutaneous insulin infusions pumping (CGMS) systems. Beside insulin treatment T1D management needs patients to track their diet habits and activities plus perform regular glucose tests to prevent dangerous blood sugar levels. Our aim is to manage blood glucose values at certain levels to decrease the chances of developing diabetes complications.
**Technology and Healthcare**
Technology has transformed how healthcare manages chronic diseases across all settings of care. Modern medical devices such as CGM systems insulin pumps and artificial pancreas systems revolutionize how healthcare professionals handle diabetes. Our new technologies show blood sugar levels in real time while controlling insulin actions and sharing performance results. New digital healthcare tools help patients talk to doctors online in real time which makes them visit hospitals less often.
**Improving Health Outcomes through Technology**
New technology enhances T1D management by showing blood sugar data in real time plus alerts patients before extreme glucose changes and decreases their risk of severe hypoglycemia and hyperglycemia. The healthcare provider monitors patient glucose data from a distance and customizes health care approach based on results. The diabetes management mobile apps allow patients to measure their food carbs while recording their insulin and exercise habits. Researchers test how machine learning and artificial intelligence technologies can identify future blood sugar patterns and suggest custom insulin changes.
**Chosen Evidence-Based Technology Use in Disease Management**
Continuous Glucose Monitoring (CGM) technology has emerged as an important tool to manage Type 1 diabetes better. CGMs show blood sugar numbers right now and help detect dangerous blood sugar drops and rises which enable better T1D handling. With CGMs patients avoid frequent fingerprick blood tests because these devices directly monitor glucose levels from beneath the skin.
**Benefits of CGM Use**
Research proves that continuous glucose monitoring (CGM) systems lower HbA1c readings while making glucose levels more steady and lowering how often severe hypoglycemia happens (Majidi et al., 2021). CGMs help patients better control their condition while lowering diabetes stress and enhancing their lifestyle. CGM systems help patients spot dangerous blood sugar levels so they can start treatment at once to avoid health problems. Shoppers today can connect their CGMs to smartphone applications which show their blood sugar levels in real time and let them pass results to doctors for better care. CGMs help parents monitor their children's blood sugar levels from any location which brings peace to both parties.
**Challenges of CGM Use**
While CGM offers many benefits new users encounter substantial issues including high expense and limited availability plus short sensor life. Insurance companies do not support CGM payment which becomes expensive for many patients to afford. Some patients find sensor placement uncomfortable and deal with too many data points that cause them to get tired of using the system. The device shows imprecise measurements when the user has incorrect hydration levels or improper device setup steps. Technology enhancements create better CGMs that are easier to use and less expensive (Eberle & Stichling, 2021). Modern CGM systems let users wear sensors for longer periods because both sensor and pump connect automatically during factory calibration.
**Conclusion**
Technology integration in diabetes care brings better healthcare results especially to Type 1 Diabetes patients. Continuous Glucose Monitoring technology leads to improved blood sugar control and reduced health problems while making life for patients much better. The future of diabetes treatment depends on new developments in digital health through artificial pancreas technology which regulates insulin delivery based on live glucose measurements. Healthcare technology advances require us to make patient resources available at reasonable costs while teaching people how to use these tools effectively. Medical groups and government agencies must work together with research experts to provide people with new diabetes control methods. Using technology systems can help healthcare teams deliver better care to people with T1D which leads to better health results and enhances their daily life.
References
Addala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., … & Holl, R. W. (2021). A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison.
_Diabetes Care_,
_44_(1), 133-140.
[https://doi.org/10.2337/dc20-0257](https://doi.org/10.2337/dc20-0257)
Agarwal, S., Schechter, C., Gonzalez, J., & Long, J. A. (2021). Racial–ethnic disparities in diabetes technology use among young adults with type 1 diabetes.
_Diabetes Technology & Therapeutics_,
_23_(4), 306-313.
[https://doi.org/10.1089/dia.2020.0338](https://doi.org/10.1089/dia.2020.0338)
Eberle, C., & Stichling, S. (2021). Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: systematic meta-review.
_Journal of medical Internet research_,
_23_(2), e23244.
[https://doi.org/10.2196/23244](https://doi.org/10.2196/23244)
Majidi, S., Ebekozien, O., Noor, N., Lyons, S. K., McDonough, R., Gandhi, K., … & T1D Exchange Quality Improvement Collaborative Study Group. (2021). Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative.
_Clinical Diabetes_,
_39_(3), 278-283.
[https://doi.org/10.2337/cd21-0028](https://doi.org/10.2337/cd21-0028)
**## Thisisthesecondpartandprofessorfeedbackoffirstpart.docx**
**This is the second part and professor feedback of first part**
**Feedback** make sure to use an appropriate tool on week 12 when evaluating the outcomes,
**Chosen Evidence-Based Technology Use in Disease or Risk Factor**
-Describe and summarize the evidence-based technology identified that has been shown to improve the condition or Risk Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this technology use chosen.
**Conclusion**
-Recap points discussed in the paper
-Importance of advancements in technology
**Signature Assignment. Submit the complete paper including the conclusion**
Completion requirements
**Opened:** Monday, March 24, 2025, 11:00 AM
**Due:** Sunday, March 30, 2025, 11:00 PM
Full description of the assignment is included at the end of the syllabus.
In this section the students needs to submit a complete assignment. Which includes: Introduction, Body and Conclusion.
Introduction:
**Introduction:**
Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality of life
**Body of the Paper**
**Global Burden of Disease Condition/Risk Factor**
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be found?
-How is it diagnosed and treated?
**Technology and Healthcare**
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your population
**## DiabetesType11.docx**
Diabetes Type 1: Improving Outcomes through Technology
Student
Instructor
University affiliation
Class Name
Date
**Diabetes Type 1: Improving Outcomes through Technology**
**Introduction**
Children and young adults develop Type 1 diabetes which needs continuous life-long healthcare. The immune system accidentally damages pancreatic beta cells that make insulin which causes insulin to drop below normal levels. Type 2 diabetes normally develops because of unhealthy behaviors yet Type 1 diabetes depends mainly on genetics and surrounding conditions. The world experiences rising numbers of people affected by T1D which now totals 9 million cases. People with T1D need to control their blood sugar levels to avoid developing life-threatening DKA and avoid nerve and heart diseases plus eye problems (Addala et al., 2021). Uncontrolled diabetes causes patients to need frequent hospital visits and eventually becomes disabling. As technology keeps advancing people with diabetes can now receive better treatment options to improve their health and daily life. Advanced digital health solutions such as CGM and insulin pumps alongside digital health technology now help patients manage their diabetes care better.
**Global Burden of Disease Condition**
The global health problem of T1D mainly affects children and teenagers with no age or geographic boundaries. More T1D cases require us to find better ways to provide healthcare services to patients. People with Type 1 Diabetes need insulin treatment to survive since their condition differs from Type 2 which responds to lifestyle changes. The body's immune system starts hurting the pancreas for no clear reasons with T1D and this disease develops unpredictably (Agarwal et al., 2021).
**Signs and Symptoms**
T1D develops when patients show hyperglycemic effects such as intense thirst (polydipsia), heavy urination (polyuria), unexpected weight loss, persistent tiredness, and vision problems. Young people typically display changes in their moods and do not pay attention well during class time. When T1D remains untreated it turns into DKA which becomes an emergency condition that causes strong nausea and vomiting plus stomach pain alongside sweet breath smells and confusion before putting a patient into a coma. Patients need urgent medical care at the hospital to treat DKA.
**Diagnosis and Treatment**
Doctors identify Type 1 diabetes using multiple blood measurements including how patients handle fasting glucose levels and HbA1c alongside tests for autoantibodies linked to diabetes. When people with diabetes experience symptoms and their blood sugar levels exceed 200 mg/dL on a random test it signifies they have the condition. Patients who receive their T1D diagnosis need permanent insulin treatment either through multiple daily injections or continuous subcutaneous insulin infusions pumping (CGMS) systems. Beside insulin treatment T1D management needs patients to track their diet habits and activities plus perform regular glucose tests to prevent dangerous blood sugar levels. Our aim is to manage blood glucose values at certain levels to decrease the chances of developing diabetes complications.
**Technology and Healthcare**
Technology has transformed how healthcare manages chronic diseases across all settings of care. Modern medical devices such as CGM systems insulin pumps and artificial pancreas systems revolutionize how healthcare professionals handle diabetes. Our new technologies show blood sugar levels in real time while controlling insulin actions and sharing performance results. New digital healthcare tools help patients talk to doctors online in real time which makes them visit hospitals less often.
**Improving Health Outcomes through Technology**
New technology enhances T1D management by showing blood sugar data in real time plus alerts patients before extreme glucose changes and decreases their risk of severe hypoglycemia and hyperglycemia. The healthcare provider monitors patient glucose data from a distance and customizes health care approach based on results. The diabetes management mobile apps allow patients to measure their food carbs while recording their insulin and exercise habits. Researchers test how machine learning and artificial intelligence technologies can identify future blood sugar patterns and suggest custom insulin changes.
**Chosen Evidence-Based Technology Use in Disease Management**
Continuous Glucose Monitoring (CGM) technology has emerged as an important tool to manage Type 1 diabetes better. CGMs show blood sugar numbers right now and help detect dangerous blood sugar drops and rises which enable better T1D handling. With CGMs patients avoid frequent fingerprick blood tests because these devices directly monitor glucose levels from beneath the skin.
**Benefits of CGM Use**
Research proves that continuous glucose monitoring (CGM) systems lower HbA1c readings while making glucose levels more steady and lowering how often severe hypoglycemia happens (Majidi et al., 2021). CGMs help patients better control their condition while lowering diabetes stress and enhancing their lifestyle. CGM systems help patients spot dangerous blood sugar levels so they can start treatment at once to avoid health problems. Shoppers today can connect their CGMs to smartphone applications which show their blood sugar levels in real time and let them pass results to doctors for better care. CGMs help parents monitor their children's blood sugar levels from any location which brings peace to both parties.
**Challenges of CGM Use**
While CGM offers many benefits new users encounter substantial issues including high expense and limited availability plus short sensor life. Insurance companies do not support CGM payment which becomes expensive for many patients to afford. Some patients find sensor placement uncomfortable and deal with too many data points that cause them to get tired of using the system. The device shows imprecise measurements when the user has incorrect hydration levels or improper device setup steps. Technology enhancements create better CGMs that are easier to use and less expensive (Eberle & Stichling, 2021). Modern CGM systems let users wear sensors for longer periods because both sensor and pump connect automatically during factory calibration.
**Conclusion**
Technology integration in diabetes care brings better healthcare results especially to Type 1 Diabetes patients. Continuous Glucose Monitoring technology leads to improved blood sugar control and reduced health problems while making life for patients much better. The future of diabetes treatment depends on new developments in digital health through artificial pancreas technology which regulates insulin delivery based on live glucose measurements. Healthcare technology advances require us to make patient resources available at reasonable costs while teaching people how to use these tools effectively. Medical groups and government agencies must work together with research experts to provide people with new diabetes control methods. Using technology systems can help healthcare teams deliver better care to people with T1D which leads to better health results and enhances their daily life.
References
Addala, A., Auzanneau, M., Miller, K., Maier, W., Foster, N., Kapellen, T., … & Holl, R. W. (2021). A decade of disparities in diabetes technology use and HbA1c in pediatric type 1 diabetes: a transatlantic comparison.
_Diabetes Care_,
_44_(1), 133-140.
[https://doi.org/10.2337/dc20-0257](https://doi.org/10.2337/dc20-0257)
Agarwal, S., Schechter, C., Gonzalez, J., & Long, J. A. (2021). Racial–ethnic disparities in diabetes technology use among young adults with type 1 diabetes.
_Diabetes Technology & Therapeutics_,
_23_(4), 306-313.
[https://doi.org/10.1089/dia.2020.0338](https://doi.org/10.1089/dia.2020.0338)
Eberle, C., & Stichling, S. (2021). Clinical improvements by telemedicine interventions managing type 1 and type 2 diabetes: systematic meta-review.
_Journal of medical Internet research_,
_23_(2), e23244.
[https://doi.org/10.2196/23244](https://doi.org/10.2196/23244)
Majidi, S., Ebekozien, O., Noor, N., Lyons, S. K., McDonough, R., Gandhi, K., … & T1D Exchange Quality Improvement Collaborative Study Group. (2021). Inequities in health outcomes in children and adults with type 1 diabetes: data from the T1D Exchange Quality Improvement Collaborative.
_Clinical Diabetes_,
_39_(3), 278-283.
[https://doi.org/10.2337/cd21-0028](https://doi.org/10.2337/cd21-0028)